Brief: Shield Therapeutics Reports Q1 2026 Group Net Revenues Of $18 Million
01/05/2026 07:24
May 1 (Reuters) - Shield Therapeutics PLC STXS.L: SHIELD THERAPEUTICS - Q1 2026 TRADING UPDATE SHIELD THERAPEUTICS PLC - Q1 2026 GROUP NET REVENUES $18M SHIELD THERAPEUTICS PLC - Q1 2026 EBIT ABOUT $2.5M Source text: ID:nRSA6954Ca Further company coverage: STXS.L ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shield Therapeutics
See all newsShield Therapeutics - Grant of Share Options
Brief: Shield Therapeutics Reports Q1 2026 Group Net Revenues Of $18 Million
Shield Therapeutics - Q1 2026 Trading Update
Brief: Shield Therapeutics Reports 2025 Group Net Revenues & Other Income At $49.7 Million
Shield Therapeutics - Audited results for year ended 31 December 2025